T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and...
T2 Biosystems, (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today operating...
View ArticleOrthoPediatrics Reports Fourth Quarter and Full Year 2017 Financial Results
OrthoPediatrics (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the fourth quarter and full year ended December...
View ArticleMexico’s COFEPRIS (Mexico’s equivalent of the FDA) approves Biomerica...
Biomerica (Nasdaq:BMRA) announced the Mexico’s COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios – Mexico’s equivalent of the U.S. Food & Drug Administration) approval of the...
View ArticleAlpha Pro Tech Announces Financial Results for the Fourth Quarter and Year...
Alpha Pro Tech (NYSE:APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced...
View ArticleNova Leap Health Reports Fourth Quarter and Full Year 2017 Financial Results
NOVA LEAP HEALTH (TSXV:NLH) a company focused on the home health care industry, is pleased to announce the release of financial results for the fourth quarter and full year ended December 31, 2017....
View ArticleMedtronic Receives FDA Approval for Guardian Connect Continuous Glucose...
Medtronic (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received U.S. Food and Drug Administration (FDA) approval for its Guardian(TM) Connect...
View ArticleAvalon GloboCare Reports 75% Increase in Revenue for the Year Ended 2017
Avalon GloboCare (OTCQB: AVCO), a leading global developer of cell-based technologies, today announced financial results and provided a business update for the year ended December 31, 2017. As quoted...
View ArticleCellular Biomedicine Group Announces Positive 48-Week Clinical Data of AlloJoin
Cellular Biomedicine Group (NASDAQ:CBMG) a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today...
View ArticleNova Leap Health Announces Execution of Definitive Agreement to Acquire Home...
NOVA LEAP HEALTH (TSXV:NLH) is pleased to announce that it has executed a definitive agreement (“the Agreement”) to acquire a home care services company (“the Target”) located in New England. As...
View ArticleiKang Announces Unaudited Financial Results for the Fiscal Third Quarter...
iKang Healthcare Group (Nasdaq:KANG), major provider in China’s fast growing private preventive healthcare services market, today announced its unaudited financial results for the fiscal third quarter...
View ArticleOPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type...
OPKO Health (NASDAQ:OPK) has enrolled the first patient in a Phase 2b dose escalation trial of OPK88003, a once-weekly oxyntomodulin therapy containing dual agonist activity towards GLP-1 and Glucagon...
View ArticleEvolus Phase III European – Canadian Head-to-Head Trial of prabotulinumtoxinA...
Evolus (NASDAQ:EOLS) a medical aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, today announced the presentation of data from the...
View ArticleBioCorRx Provides Business Update for the Full Year Ended 2017
BioCorRx (OTCQB: BICX) a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today provided a business update for the year ended December 31, 2017. As...
View ArticleRelevium Targets 83 Million Unique Monthly Visitors and 26 Countries Through...
Relevium Technologies (TSXV:RLV) is pleased to announce that it has started the process of establishing European presence for the new Bioganix® brand in partnership with several online partners,...
View ArticleBrain Armor Announces Distribution at Walmart
Brain Armor an innovative nutrition company dedicated to improving cognitive health and performance on every field of play and a subsidiary of Trident Brands (OTCQB:TDNT), has announced new...
View ArticleSientra Receives FDA Approval of PMA Supplement
Sientra (NASDAQ:SIEN) a medical aesthetics company, today announced U.S. Food and Drug Administration (FDA) approval of the Company’s PMA supplement allowing commercialization of its OPUS-branded...
View ArticleTivity Health Reports First-Quarter 2018 Results and Affirms Financial Guidance
Tivity Health (NASDAQ:TVTY) announced financial results for the first quarter ended March 31, 2018 and appointed marketing industry veteran Arra Yerganian to the newly created role of Chief Brand...
View ArticleEvolus Announces Progress with DWP-450 Regulatory Submissions
Evolus (NASDAQ:EOLS) a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, today announced updates related to the regulatory...
View ArticleAnthem to Acquire Aspire Health
Anthem (NYSE:ANTM) today announced that the company has entered into an agreement to acquire Aspire Health, the nation’s largest non-hospice, community-based palliative care provider. As quoted in the...
View ArticleCutera Announces Expansion of FDA Indications for the truSculpt® Body...
CUTERA (Nasdaq:CUTR) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announced the U.S. Food and Drug Administration (FDA) has granted...
View Article
